Resistin and obesity-associated insulin resistance

Trends in Endocrinology and Metabolism

Volumn 13, Issue 1, 2002, Pages 18-23

  Steppan, Claire M ^a   Lazar, Mitchell A ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ADIPONECTIN; ANTIDIABETIC AGENT; HORMONE RECEPTOR; INSULIN; INTERLEUKIN 6; LEPTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RESISTIN; TUMOR NECROSIS FACTOR ALPHA; HORMONE;

ADIPOCYTE; ADIPOSE TISSUE; CELL SECRETION; DISEASE ASSOCIATION; DOWN REGULATION; GENETIC TRANSCRIPTION; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN SECRETION; RECEPTOR BINDING; REVIEW; RISK FACTOR; ANIMAL; ENDOCRINE GLAND; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADIPOSE TISSUE; ANIMAL; ENDOCRINE GLANDS; HORMONES, ECTOPIC; INSULIN RESISTANCE; OBESITY; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0036134187     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(01)00522-7     Document Type: Review

References (77)

1. Saltiel, A.R. (2001) New perspectives into the molecular pathogenesis and treatment of type 2 diabetes. Cell 104, 517-529
2. Kahn, B.B. and Flier, J.S. (2000) Obesity and insulin resistance. J. Clin. Invest. 106, 473-481
3. DeFronzo, R.A. et al. (1992) Pathogenesis of NIDDM. A balanced overview. Diabetes Care 15, 318-368
4. Evans, D.J. et al. (1984) Relationship of body fat tomography to insulin sensitivity and metabolic profile in premenopausal woman. Metabolism 36, 68-75
5. Kelley, D.E. et al. (2000) Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance. Am. J. Physiol. 278, E941-E948
6. Coppack, S.W. et al. (1994) In vivo regulation of lipolysis in humans. J. Lipid Res. 35, 177-193
7. Reynisdottir, S. et al. (1994) Multiple lipolysis defects in insulin resistance (metabolic) syndrome. J. Clin. Invest. 93, 2590-2599
8. Abel, E.D. et al. (2001) Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 409, 729-733
9. Zhang, Y. et al. (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425-432
10. Montague, C.T. et al. (1997) Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387, 903-908
11. Chen, H. et al. (1996) Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 84, 491-495
12. Clement, K. et al. (1998) A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 26, 398-401
13. Friedman, J. (1998) Leptin, leptin receptors, and the control of body weight. Nutr. Rev. 56, s38-s46; discussion, s54-s74
14. Campfield, L.A. et al. (1995) Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 269, 546-549
15. Halaas, J.L. and Friedman, J. (1995) Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269, 543-546
16. Pelleymounter, M.A. et al. (1995) Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269, 540-543
17. Halaas, J.L. et al. (1997) Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc. Natl. Acad. Sci. U. S. A. 94, 8878-8883
18. Ahima, R.S. et al. (1996) Role of leptin in the neuroendocrine response to fasting. Nature 382, 250-252
19. Golay, A. et al. (1986) Effect of differences in glucose tolerance on insulin's ability to regulate carbohydrate and free fatty acid metabolism in obese individuals. J. Clin. Endocrinol. Metab. 62, 1081-1088
20. Scherer, P.E. et al. (1995) A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol. Chem. 270, 26746-26749
21. Hu, E. et al. (1996) AdipoQ is a novel adipose-specific gene dysregulated in obesity. J. Biol. Chem. 271, 10697-10703
22. Maeda, K. (1996) cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (adipose most abundant gene transcript 1). Biochem. Biophys. Res. Commun. 221, 286-289
23. Hotamisligil, G. et al. (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259, 87-91
24. Cook, K.S. et al. (1986) A developmentally regulated mRNA from 3T3 adipocytes encodes a novel serine protease homologue. Proc. Natl. Acad. Sci. U. S. A. 82, 6480-6484
25. Wiman, B. et al. (1984) Inactivation of tissue plasminogen activator in plasma: demonstration of a complex with a rapid new inhibitor. J. Biol. Chem. 209, 3644-3647
26. Maslowska, M. et al. (1997) Acute in vivo production of acylation stimulating protein in differentiated human adipocytes. J. Lipid Res. 38, 1-11
27. Mohamed-Ali, V. et al. (1997) Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-α, in vivo. J. Clin. Endocrinol. Metab. 82, 4196-4200
28. Bruun, J.M. et al. (2001) Regulation of interleukin 8 production and gene expression in human adipose tissue in vitro. J. Clin. Endocrinol. Metab. 86, 1267-1273
29. Manne, J. et al. (1995) Mechanisms for the pleiotropic effects of the agouti gene. Proc. Natl. Acad. Sci. U. S. A. 92, 4721-4724
30. Samad, F. and Loskuttof, D.J. (1996) Elevated expression of transforming growth factor-β in adipose tissue from obese mice. Mol. Med. 2, 568-582
31. Jones, B.H. et al. (1997) Angiotensinogen gene expression in adipose tissue: analysis of obese models and hormonal and nutritional control. Am. J. Physiol. 273, R236-R242
32. Heid, H.W. et al. (1998) Adipophilin is a specific marker of lipid accumulation in diverse cell types and diseases. Cell Tissue Res. 294, 309-321
33. Friedman, J.M. and Halaas, J.L. (1998) Leptin and the regulation of body weight in mammals. Nature 395, 763-770
34. Flier, J.S. (1998) What's in a name? In search of leptin's physiologic role. J. Clin. Endocrinol. Metab. 83, 1407-1413
35. Ahima, R.S. and Flier, J.S. (2000) Leptin. Annu. Rev. Physiol. 62, 413-437
36. Shimomura, I. et al. (1999) Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature 401, 73-76
37. Gavrilova, O. et al. (2000) Leptin and diabetes in lipoatrophic mice. Nature 403, 850
38. Maffei, M. et al. (1995) Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat. Med. 1, 1155-1161
39. Tartaglia, L.A. (1997) The leptin receptor. J. Biol. Chem. 272, 6093-6096
40. Sivitz, W. et al. (1997) Effects of leptin on insulin sensitivity in normal rats. Endocrinology 139, 3863-3870
41. Harris, R. (1998) Acute and chronic effects of leptin on glucose utilization in lean mice. Biochem. Biophys. Res. Commun. 245, 502-509
42. Cohen, B. et al. (1996) Modulation of insulin activities by leptin. Science 274, 1185-1188
43. Rossetti, L. et al. (1997) Short term effects of leptin on hepatic gluconeogenesis and in vivo insulin action. J. Biol. Chem. 272, 27758-27763
44. Wauters, M. et al. (2000) Human leptin: from an adipocyte hormone to an endocrine mediator. Eur. J. Endocrinol. 143, 293-311
45. Beutler, B. and Cerami, A. (1988) Cachectin (tumor necrosis factor): a macrophage hormone governing cellular metabolism and inflammatory response. Endocr. Rev. 9, 57-66
46. Hotamisligil, G. and Spiegelman, B. (1994) Tumor necrosis factor-α: a key component of the obesity-diabetes link. Diabetes 43, 1271-1278
47. Moller, D.E. (2000) Potential role of TNF-α in the pathogenesis of insulin resistance and type 2 diabetes. Trends Endocrinol. Metab. 11, 212-217
48. Stephens, J.M. and Pekala, P.H. (1991) Transcriptional repression of the GLUT4 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha. J. Biol. Chem. 266, 21839-21845
49. Stephens, J. et al. (1997) Tumor necrosis factor-α-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin receptor-mediated signal transduction. J. Biol. Chem. 272, 971-976
50. Lang, C.H. et al. (1992) Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Endocrinology 130, 43-52
51. Ventre, J. et al. (1997) Targeted disruption of the tumor necrosis factor α gene: metabolic consequences in obese and non-obese mice. Diabetes 46, 1526-1531
52. Uysal, K.T. et al. (1997) Protection from obesity-induced insulin resistance in mice lacking TNF-α function. Nature 389, 610-614
53. Schreyer, S.A. et al. (1998) Obesity and diabetes in TNF-α receptor-deficient mice. J. Clin. Invest. 102, 402-411
54. Arita, Y. et al. (1999) Paradoxical decrease of an adipose-specific protein, adiponectin in obesity. Biochem. Biophys. Res. Commun. 257, 79-83
55. Nakano, Y. et al. (1996) Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J. Biochem. 120, 803-812
56. Weyer, C. et al. (2001) Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J. Clin. Endocrinol. Metab. 86, 1930-1935
57. Berg, A.H. et al. (2001) The adipocyte-secreted protein Acrp 30 enhances hepatic insulin action. Nat. Med. 7, 947-953
58. Yamauchi, T. et al. (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 7, 941-946
59. Shapiro, L. and Scherer, RE. (1998) The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor. Curr. Biol. 8, 335-338
60. Fruebis, J. et al. (2001) Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc. Natl. Acad. Sci. U. S. A. 98, 2005-2010
61. Fried, S.K. et al. (1998) Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation of glucocorticoid. J. Clin. Endocrinol. Metab. 83, 847-850
62. Mohamed-Ali, V. et al. (1999) Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo. Am. J. Physiol. Endocrinol. Metab. 277, E971-E975
63. Bastard, J. et al. (2000) Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese woman after weight loss. J. Clin. Endocrinol. Metab. 85, 3338-3342
64. Fruhbeck, G. et al. (2001) The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am. J. Physiol. 280, E827-E847
65. Reginato, M.J. and Lazar, M.A. (1999) Mechanisms by which thiazolidinediones enhance insulin action. Trends Endocrinol. Metab. 10, 9-13
66. Auwerx, J. (1999) PPARgamma, the ultimate thrifty gene. Diabetologia 42, 1033-1049
67. Steppan, C.M. et al. (2001) The hormone resistin links obesity to diabetes. Nature 409, 307-312
68. Kim, K-H. et al. (2001) A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J. Biol. Chem. 276, 11252-11256
69. Holcomb, I.N. et al. (2000) FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J. 19, 4046-4050
70. Steppan, C.M. et al. (2001) A family of tissue-specific resistin-like molecules. Proc. Natl. Acad. Sci. U. S. A. 98, 502-506
71. Banerjee, R.R. and Lazar, M.A. (2001) Dimerization of resistin and resistin-like molecules is determined by a single cysteine. J. Biol. Chem. 276, 25970-25973
72. Way, J.M. et al. (2001) Adipose tissue resistin expression is severely suppressed in obesity and stimulated by PPARγ agonists. J. Biol. Chem. 276, 25651-25653
73. Hotta, K. et al. (2001) Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 50, 1126-1133
74. Moore, G.B. et al. (2001) Differential regulation of adipocytokine mRNAs by rosiglitazone in db/db mice. Biochem. Biophys. Res. Commun. 286, 735-741
75. Yamauchi, T. et al. (2001) Inhibition of RXR and PPARγ ameliorates diet-induced obesity and type 2 diabetes. J. Clin. Invest. 108, 1001-1013
76. Savage, D.B. et al. (2001) Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-γ action in humans. Diabetes 50, 2199-2202
77. Nagaev, I. and Smith, U. (2001) Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. Biochem. Biophys. Res. Commun. 285, 561-564